Clinical Guidelines

Local Primary Care Networks (PCNs) are being established by clinical commission groups (CCGs) to facilitate and encourage GP practices to work together in clusters with community, mental health, [...]

This SIGN guideline was published in January 2019 and is expected to be of interest to those involved in the assessment and diagnosis of people at risk of fetal alcohol spectrum disorder (FASD), [...]

The Royal Pharmaceutical Society has recently revised and updated its guidance on the safe and secure handling of medicines, formally known as The Duthie Report, and it has produced a framework [...]

Homely remedies, also known as discretionary medicines, are non-prescription medicines that can be used to treat minor self-limiting health problems. Examples would include mild painkillers such [...]

Vitamin D is important to maintain bone health but also appears to be associated with the prevention of auto-immune disease, cancer, mental health problems and cardiovascular disease. Deficiency [...]

This SIGN guideline, published in September 2018, covers recommendations for the management of cardiac arrest and the arrhythmias associated with ACS, chronic CHD and cardiac surgery. It makes [...]

Each year, the Care Quality Commission (CQC) publishes a report on the management of Controlled Drugs in England. Good practice and issues relating to Controlled Drugs are shared by the CQC with [...]

The British Association of Psychopharmacology (BAP) and the National Association of Psychiatric Intensive Care and Low Secure Units (NAPICU) issued their joint guidance on the clinical management [...]

This NICE key therapeutic topic was updated in February 2018 and summarises the evidence base on medicines optimisation in long-term pain, in order that the right medication is being used for [...]

This NICE clinical guideline was updated in December 2017 and covers recognising and diagnosing autism spectrum disorder in children and young people from birth up to 19 years. It also covers [...]